查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1603889

到 2030 年馬醫療保健市場預測：按產品類型、動物類型、疾病類型、分銷管道、最終用戶和地區進行的全球分析

Equine Healthcare Market Forecasts to 2030 - Global Analysis By Product Type (Therapeutics, Diagnostics, Supplemental Nutrition and Other Product Types), Animal Type, Disease Type, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球馬保健品市場規模將達到 36 億美元，預計到 2030 年將達到 65 億美元，預測期內複合年成長率為 10.3%。

馬匹保健是一門透過醫療、營養和管理實踐關注馬匹健康和福祉的專業。常規獸醫護理包括疫苗接種和牙科檢查，以預防絞痛、蹄葉炎和呼吸道感染疾病等常見疾病。蹄鐵匠對馬蹄進行適當的護理可確保您的馬的活動能力並降低跛行的風險。我們根據年齡、活動量和健康狀況提供均衡的乾草、穀物和補充品組合的客製化膳食。運動管理對於健身、心理健康和預防傷害至關重要。馬匹保健也涉及生殖健康，協助繁殖、懷孕和馬駒護理。

據 2024 年 2 月《歐洲新聞》新聞稿稱，哥斯達黎加科學家正在參與研究和開發人類蛇咬傷的解毒劑。他們利用馬作為容器來開發疫苗抗體。

馬疾病增加

由於馬匹疾病的增加以及對獸醫護理、診斷和治療的相關需求，針對馬匹的醫療保健服務正在增加。醫院和獸醫診所患者數量的增加是這項需求的主要驅動力。由於馬病發病率不斷上升，以及對血液檢測、影像檢查和基因檢測等精確診斷方法的需求，對先進診斷技術的需求也很高。

農村地區獲得獸醫護理的機會有限

由於農村地區獲得獸醫服務的機會有限，尋求定期治療的馬主越來越少。這導致對馬保健產品和服務的需求較低，限制了市場滲透率。此外，未經治療的疾病可能無法確診並導致感染疾病和嚴重症狀。恢復需要更長的時間，醫療費用也會增加。因此，及時的獸醫干預對於緩解這些問題並提高這些地區馬匹的整體生活品質至關重要。

提升馬主和獸醫對馬匹健康的認知

人們對馬健康問題的認知不斷提高，導致馬主尋求獸醫服務的趨勢不斷增加。因此，對定期檢查、疫苗接種和專門治療的需求不斷增加。隨著越來越多的馬主優先考慮馬匹的健康，常規疫苗接種和寄生蟲控制等預防性護理市場預計將會成長。人們對預防措施的興趣日益濃厚，促進了疫苗、診斷工具和其他旨在維持馬匹健康的醫療保健產品市場的成長。

缺乏熟練的獸醫

隨著執業馬獸醫數量的減少，馬主很難得到及時的獸醫護理。許多診所都在努力接受新客戶，預約和緊急服務的等待時間很長。這種有限的獲取機會導致健康問題不受治療，對馬匹福利產生負面影響，增加嚴重健康併發症的風險，並阻礙市場成長。

COVID-19 的影響

COVID-19大流行顯著加速了各領域對服務機器人的需求。為了最大限度地減少人際接觸並保持業務連續性，機器人迅速被引入醫療保健、物流和消毒服務領域。在倉庫和零售業，機器人回應了日益成長的電子商務需求。這一激增凸顯了機器人在提高效率和安全性方面的價值，促進了疫情後服務機器人的長期投資和創新。

預計治療領域在預測期內將是最大的

由於擴大採用抗感染藥、疫苗、止痛藥和再生療法，治療領域估計是最大的。這一成長是由馬主和設施對疾病預防和治療方案的投資增加所推動的。治療方法在疾病控制和預防、支持牛健康和減少代價高昂的疫情爆發方面也發揮著重要作用。

預計萊姆病產業在預測期內複合年成長率最高

由於馬萊姆病需要複雜的診斷程序，包括 ELISA 等血清學測定以及蛋白質印跡和螢光測定等驗證測試，因此萊姆病部分預計在預測期內出現最高的複合年成長率。馬萊姆病多重檢測等先進診斷工具可提高早期檢測和準確性，這對於有效治療至關重要。因此，對全面診斷服務的需求以及馬主對萊姆病認知的提高正在推動市場的成長。

比最大的地區

由於該地區（尤其是中國、日本和澳洲）馬術比賽的快速成長，導致對馬保健產品的需求不斷增加，預計亞太地區將在預測期內佔據最大的市場佔有率。這項需求的推動因素是賽馬、馬術障礙賽和馬球運動的參與度增加，以及疫苗、抗感染劑和補充品等解決常見馬匹健康問題的重要性，這是因為性取向正在增加。

複合年成長率最高的地區：

預計北美在預測期內的複合年成長率最高。北美強大的獸醫基礎設施為馬術專家、診所和醫院提供了便利。透過提供專業、高品質的護理，市場正在不斷擴大。對破傷風、馬流感和西尼羅河病毒等馬疾病的需求不斷增加，也推動了對疫苗、驅蟲產品和補充品等預防性治療的大量投資。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球馬保健市場：依產品類型

  • 治療藥物
    • 疫苗
    • 抗感染劑
    • 寄生劑
    • 發炎藥
  • 診斷
    • 臨床病理學
    • 免疫檢測
    • 分子診斷
    • 影像技術
  • 食品補充品
    • 飼料添加劑
    • 表現補充品
  • 其他產品類型

第6章全球馬保健市場：依動物類型

  • 比賽馬
  • 休閒馬
  • 工作馬
  • 賽馬
  • 其他動物類型

第7章全球馬醫療保健市場：依疾病類型

  • 馬流感
  • 萊姆病
  • 破傷風
  • 狂犬病
  • 馬腦脊髓炎
  • 肌肉骨骼疾病
  • 西尼羅病毒
  • 狂犬病
  • 其他類型的疾病

第8章全球馬保健市場：依通路分類

  • 動物醫院/診所
  • 電子商務
  • 零售藥局/藥局
  • 其他分銷管道

第9章全球馬醫療保健市場：依最終用戶分類

  • 動物醫院
  • 動物診所
  • 調查機構
  • 其他最終用戶

第10章全球馬保健市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、合作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章 公司概況

  • Arthrex Inc.
  • Boehringer Ingelheim International GmbH
  • Cargill
  • Ceva Sante Animale
  • Covetrus Inc.
  • Dechra Pharmaceuticals
  • Elanco
  • Esaote SPA
  • Hallmarq Veterinary Imaging
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • Kyoritsuseiyaku Corporation
  • Merck & Co. Inc
  • Neogen Corporation
  • Purina Animal Nutrition LLC.
  • Vetoquinol SA
  • Zoetis
Product Code: SMRC27911

According to Stratistics MRC, the Global Equine Healthcare Market is accounted for $3.6 billion in 2024 and is expected to reach $6.5 billion by 2030 growing at a CAGR of 10.3% during the forecast period. Equine healthcare is a specialized field that focuses on the health and well-being of horses through medical care, nutrition, and management practices. It includes routine veterinary care, such as vaccinations and dental exams, to prevent common diseases like colic, laminitis, and respiratory infections. Proper hoof care by farriers ensures horses' mobility and reduces lameness risk. Nutrition is a core component, with tailored diets balancing hay, grains, and supplements based on age, activity level, and health status. Exercise management is crucial for fitness, mental well-being, and injury prevention. Equine healthcare also addresses reproductive health, assisting with breeding, pregnancy, and foal care.

According to a February 2024 press release by Euro News, scientists from Costa Rica are involved in R&D to develop antidotes for human snake bites. They are utilizing the horses as the vessels to develop antibodies against the vaccine.

Market Dynamics:

Driver:

Rising incidence of equine diseases

Specialized horse healthcare services have increased as a result of the rise in equine diseases and the resulting demand for veterinary care, diagnosis, and treatments. Increased patient loads in hospitals and veterinary clinics are the main cause of this demand. Advanced diagnostic technologies are also in high demand due to the rising incidence of horse diseases and the need for precise diagnostic methods such blood tests, imaging tests, and genetic testing.

Restraint:

Limited access to veterinary care in rural areas

Rural areas lack access to veterinary services, resulting in fewer horse owners seeking regular care. This leads to a lower demand for equine healthcare products and services, limiting market penetration. Untreated diseases can also go undiagnosed or untreated, causing infections and severe conditions. Long recovery times and increased healthcare costs can be exacerbated. Therefore, timely veterinary intervention is crucial to mitigate these issues and improve the overall quality of life for horses in these areas.

Opportunity:

Heightened awareness regarding equine health among horse owners and veterinarians

Horse owners are increasingly seeking veterinary services due to increased awareness about equine health issues. This leads to a higher demand for routine check-ups, vaccinations, and specialized treatments. The market for preventive care, such as regular vaccinations and parasite control, is expected to grow as more horse owners prioritize their animals' health. This increased focus on preventive measures contributes to the growth of the market for vaccines, diagnostic tools, and other healthcare products designed to maintain equine health.

Threat:

Shortage of skilled veterinarians

As the number of practicing equine veterinarians decreases, horse owners face increasing difficulties in accessing timely veterinary care. Many clinics struggle to accommodate new clients, leading to longer wait times for appointments and emergency services. This limited access can result in untreated health issues, negatively impacting horse welfare and increasing the risk of serious health complications hampering the market growth.

Covid-19 Impact

The COVID-19 pandemic significantly accelerated the demand for service robotics across various sectors. With increased emphasis on minimizing human contact and maintaining operational continuity, robots were rapidly deployed in healthcare, logistics, and disinfection services. In warehouses and retail, robots helped fulfill heightened e-commerce demands. This surge highlighted the value of robotics for efficiency and safety, driving long-term investment and innovation in service robotics post-pandemic.

The therapeutics segment is expected to be the largest during the forecast period

The therapeutics segment is estimated to be the largest, due to the increasing adoption of anti-infective drugs, vaccines, pain relievers, and regenerative therapies. This growth is driven by increased investment in disease prevention and treatment options by horse owners and facilities. Therapeutics also plays a crucial role in disease control and prevention, supporting herd health and reducing costly outbreaks.

The lyme disease segment is expected to have the highest CAGR during the forecast period

The lyme disease segment is anticipated to witness the highest CAGR during the forecast period, because lyme disease in horses requires complex diagnostic procedures, including serological assays like ELISA and confirmatory tests like Western blot or immunofluorescence assays. Advanced diagnostic tools like the Equine Lyme Multiplex Assay improve early detection and accuracy, crucial for effective treatment. Thus market growth is driven by the need for comprehensive diagnostic services and increased awareness among horse owners about Lyme disease.

Region with largest share:

Asia Pacific is expected to have the largest market share during the forecast period because the Asia Pacific, particularly China, Japan, and Australia, is experiencing a surge in equestrian sports, leading to a growing demand for equine healthcare products. This demand is driven by the growing participation in racing, show jumping, and polo, as well as the growing importance of therapeutic solutions like vaccines, anti-infectives, and supplements to address common equine health issues.

Region with highest CAGR:

North America is projected to witness the highest CAGR over the forecast period; access to expert equine doctors, clinics, and hospitals is made possible by the strong veterinary care infrastructure in North America. By providing specialized, high-quality care, this expands the market. The rising demand for horse diseases including tetanus, equine influenza, and West Nile virus is also driving a large investment in preventive treatment, including vaccines, deworming products, and supplements.

Key players in the market

Some of the key players profiled in the Equine Healthcare Market include Arthrex Inc., Boehringer Ingelheim International GmbH, Cargill, Ceva Sante Animale, Covetrus Inc., Dechra Pharmaceuticals, Elanco, Esaote SPA, Hallmarq Veterinary Imaging, Heska Corporation, IDEXX Laboratories, Inc., Kyoritsuseiyaku Corporation, Merck & Co. Inc, Neogen Corporation, Purina Animal Nutrition LLC., Vetoquinol S.A. and Zoetis

Key Developments:

In November 2024, Merck announced that Merck has entered into an exclusive global license to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova.

In October 2024, Gilead and Merck announced Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48.

In October 2024, Cargill launched new cocoa production line in Indonesia to meet growing Asian consumers' demand for indulgent foods. The new line brings innovation capabilities and competitiveness to customers in the bakery, ice cream and chocolate confectionery categories, as well as for the cafe-style beverages in foodservice.

Product Types Covered:

  • Therapeutics
  • Diagnostics
  • Supplemental Nutrition
  • Other Product Types

Animal Types Covered:

  • Performance Horses
  • Recreational Horses
  • Working Horses
  • Racehorses
  • Other Animal Types

Disease Types Covered:

  • Equine Influenza
  • Lyme Disease
  • Tetanus
  • Rabies
  • Equine Encephalomyelitis
  • Musculoskeletal Disorders
  • West Nile Virus
  • Rabies
  • Other Disease Types

Distribution Channels Covered:

  • Veterinary Hospitals & Clinics
  • E-Commerce
  • Retail Pharmacies & Drug Stores
  • Other Distribution Channels

End Users Covered:

  • Veterinary Hospitals
  • Animal Clinics
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Equine Healthcare Market, By Product Type

  • 5.1 Introduction
  • 5.2 Therapeutics
    • 5.2.1 Vaccines
    • 5.2.2 Anti-Infective Agents
    • 5.2.3 Parasiticides
    • 5.2.4 Anti-Inflammatory Drugs
  • 5.3 Diagnostics
    • 5.3.1 Clinical Pathology
    • 5.3.2 Immunoassays
    • 5.3.3 Molecular Diagnostics
    • 5.3.4 Imaging Techniques
  • 5.4 Supplemental Nutrition
    • 5.4.1 Feed Additives
    • 5.4.2 Performance Supplements
  • 5.5 Other Product Types

6 Global Equine Healthcare Market, By Animal Type

  • 6.1 Introduction
  • 6.2 Performance Horses
  • 6.3 Recreational Horses
  • 6.4 Working Horses
  • 6.5 Racehorses
  • 6.6 Other Animal Types

7 Global Equine Healthcare Market, By Disease Type

  • 7.1 Introduction
  • 7.2 Equine Influenza
  • 7.3 Lyme Disease
  • 7.4 Tetanus
  • 7.5 Rabies
  • 7.6 Equine Encephalomyelitis
  • 7.7 Musculoskeletal Disorders
  • 7.8 West Nile Virus
  • 7.9 Rabies
  • 7.10 Other Disease Types

8 Global Equine Healthcare Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Veterinary Hospitals & Clinics
  • 8.3 E-Commerce
  • 8.4 Retail Pharmacies & Drug Stores
  • 8.5 Other Distribution Channels

9 Global Equine Healthcare Market, By End User

  • 9.1 Introduction
  • 9.2 Veterinary Hospitals
  • 9.3 Animal Clinics
  • 9.4 Research Institutes
  • 9.5 Other End Users

10 Global Equine Healthcare Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Arthrex Inc.
  • 12.2 Boehringer Ingelheim International GmbH
  • 12.3 Cargill
  • 12.4 Ceva Sante Animale
  • 12.5 Covetrus Inc.
  • 12.6 Dechra Pharmaceuticals
  • 12.7 Elanco
  • 12.8 Esaote SPA
  • 12.9 Hallmarq Veterinary Imaging
  • 12.10 Heska Corporation
  • 12.11 IDEXX Laboratories, Inc.
  • 12.12 Kyoritsuseiyaku Corporation
  • 12.13 Merck & Co. Inc
  • 12.14 Neogen Corporation
  • 12.15 Purina Animal Nutrition LLC.
  • 12.16 Vetoquinol S.A.
  • 12.17 Zoetis

List of Tables

  • Table 1 Global Equine Healthcare Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Equine Healthcare Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Equine Healthcare Market Outlook, By Therapeutics (2022-2030) ($MN)
  • Table 4 Global Equine Healthcare Market Outlook, By Vaccines (2022-2030) ($MN)
  • Table 5 Global Equine Healthcare Market Outlook, By Anti-Infective Agents (2022-2030) ($MN)
  • Table 6 Global Equine Healthcare Market Outlook, By Parasiticides (2022-2030) ($MN)
  • Table 7 Global Equine Healthcare Market Outlook, By Anti-Inflammatory Drugs (2022-2030) ($MN)
  • Table 8 Global Equine Healthcare Market Outlook, By Diagnostics (2022-2030) ($MN)
  • Table 9 Global Equine Healthcare Market Outlook, By Clinical Pathology (2022-2030) ($MN)
  • Table 10 Global Equine Healthcare Market Outlook, By Immunoassays (2022-2030) ($MN)
  • Table 11 Global Equine Healthcare Market Outlook, By Molecular Diagnostics (2022-2030) ($MN)
  • Table 12 Global Equine Healthcare Market Outlook, By Imaging Techniques (2022-2030) ($MN)
  • Table 13 Global Equine Healthcare Market Outlook, By Supplemental Nutrition (2022-2030) ($MN)
  • Table 14 Global Equine Healthcare Market Outlook, By Feed Additives (2022-2030) ($MN)
  • Table 15 Global Equine Healthcare Market Outlook, By Performance Supplements (2022-2030) ($MN)
  • Table 16 Global Equine Healthcare Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 17 Global Equine Healthcare Market Outlook, By Animal Type (2022-2030) ($MN)
  • Table 18 Global Equine Healthcare Market Outlook, By Performance Horses (2022-2030) ($MN)
  • Table 19 Global Equine Healthcare Market Outlook, By Recreational Horses (2022-2030) ($MN)
  • Table 20 Global Equine Healthcare Market Outlook, By Working Horses (2022-2030) ($MN)
  • Table 21 Global Equine Healthcare Market Outlook, By Racehorses (2022-2030) ($MN)
  • Table 22 Global Equine Healthcare Market Outlook, By Other Animal Types (2022-2030) ($MN)
  • Table 23 Global Equine Healthcare Market Outlook, By Disease Type (2022-2030) ($MN)
  • Table 24 Global Equine Healthcare Market Outlook, By Equine Influenza (2022-2030) ($MN)
  • Table 25 Global Equine Healthcare Market Outlook, By Lyme Disease (2022-2030) ($MN)
  • Table 26 Global Equine Healthcare Market Outlook, By Tetanus (2022-2030) ($MN)
  • Table 27 Global Equine Healthcare Market Outlook, By Rabies (2022-2030) ($MN)
  • Table 28 Global Equine Healthcare Market Outlook, By Equine Encephalomyelitis (2022-2030) ($MN)
  • Table 29 Global Equine Healthcare Market Outlook, By Musculoskeletal Disorders (2022-2030) ($MN)
  • Table 30 Global Equine Healthcare Market Outlook, By West Nile Virus (2022-2030) ($MN)
  • Table 31 Global Equine Healthcare Market Outlook, By Rabies (2022-2030) ($MN)
  • Table 32 Global Equine Healthcare Market Outlook, By Other Disease Types (2022-2030) ($MN)
  • Table 33 Global Equine Healthcare Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 34 Global Equine Healthcare Market Outlook, By Veterinary Hospitals & Clinics (2022-2030) ($MN)
  • Table 35 Global Equine Healthcare Market Outlook, By E-Commerce (2022-2030) ($MN)
  • Table 36 Global Equine Healthcare Market Outlook, By Retail Pharmacies & Drug Stores (2022-2030) ($MN)
  • Table 37 Global Equine Healthcare Market Outlook, By Other Distribution Channels (2022-2030) ($MN)
  • Table 38 Global Equine Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 39 Global Equine Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
  • Table 40 Global Equine Healthcare Market Outlook, By Animal Clinics (2022-2030) ($MN)
  • Table 41 Global Equine Healthcare Market Outlook, By Research Institutes (2022-2030) ($MN)
  • Table 42 Global Equine Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.